How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines key variants in GLP-1 receptor signaling (GLP1R rs6923761), glucose-dependent insulinotropic peptide receptor pathways (GIPR rs1800437), and appetite regulation genes (FTO rs9939609, MC4R rs17782313)
Cristina Abreu has received research support from Sanofi, Novo Nordisk, Boehringer Ingelheim Pharmaceuticals, and Lilly, and has acted as a speaker for Sanofi, Novo Nordisk, Boehringer Ingelheim Pharmaceuticals, AstraZeneca Pharmaceuticals LP, and Bristol-Myers Squibb Co
At the same time, it is important to remember that GLP-1 is not an external invention
Toxic fat is the cause of many cardiometabolic conditions, and GLP-1 drugs can help people reclaim their health